Image For Activity Cover
Endocrine Board Review, 16th Edition
Course Description

The Endocrine Board Review (EBR) is a board examination preparation course designed both for endocrine fellows who have completed or are nearing completion of their fellowship and are preparing to sit the board certification exam and for practicing endocrinologists in search of a comprehensive self-assessment of endocrinology, either to prepare for recertification or to update their practice. EBR consists of 221 case-based, American Board of Internal Medicine (ABIM) style, multiple-choice questions in a mock exam format. Each section follows the ABIM Endocrinology, Diabetes, and Metabolism Certification Examination blueprint, covering the breadth and depth of the certification and recertification examinations. Each case is discussed comprehensively, with detailed explanations and references. A customized score report is provided to those participating in the online courses. 

EBR 2024 Bundle grants access to two main components: 

  • Endocrine Board Review 16th Edition—printed self-study book containing all 221 case-based questions and complete answer rationale.
  •  Interactive Practice Exam— Access 221 questions to evaluate your knowledge in key topical areas to enhance your ability to make appropriate diagnoses. This practice exam allows the learner to create their own test based on topical area, with options to adjust the length of time and measure confidence level in responses. You can submit questions for our faculty to address during the live Q&A sessions based on specific case questions.
    • Learning Mode: Answer 221 questions, receive immediate feedback, and view the detailed answer rationale. This mode must be completed with a passing score of 70% in order to earn CME and MOC. You will be given unlimited attempts to obtain this score.
    • Mock Exam Mode: Perfect for simulating an exam. Retake this mock exam as often as you like, and the questions will be re-organized each time. Feedback will be provided after completion of the exam.
      • Build your own exam: Within Mock Exam Mode, you have the option to create your own exams by choosing the topic(s) to be included and even setting a timer.
Target Audience
This activity is intended for endocrine fellows planning for initial certification, practicing endocrinologists preparing for an MOC assessment, or physicians seeking an in-depth review of endocrinology. The secondary target audience includes advanced practice nurses and physician assistants.
Learning Objectives

Upon completion of this educational activity, learners will be able to:

  • Demonstrate enhanced medical knowledge and clinical skills across all major areas of endocrinology.
  • Apply knowledge and skills in diagnosing, managing, and treating a wide spectrum of endocrine disorders.
  • Successfully complete the board examination for certification or recertification in the subspecialty of endocrinology, diabetes, and metabolism.
Accreditation Statement

The Endocrine Society is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. Endocrine Society has achieved Accreditation with Commendation.

The Endocrine Society designates the Endocrine Board Review 2024 Virtual Meeting for a maximum of 55 AMA PRA Category 1 Credits and 55 points in the ABIM Maintenance of Certification (MOC) program. Successful completion of this CME activity includes participation in the activity evaluation.  After completing the activity evaluation, participants will be able to save or print a CME certificate. The CME activity provider is responsible for submitting participant completion information to the ACCME to grant ABIM MOC points.  

CME credits and/or MOC points for the activities related to this material must be claimed by December 31, 2025. 

AMA PRA Category 1 Credit

The Endocrine Society designates each activity in this course for a maximum of 55 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. While offering CME credits noted above, this program is not intended to provide extensive training or certification in the field.

Please note that while other accrediting bodies accept AMA PRA Category 1 credit, we can only award and report this credit for MDs/DOs. For those outside of this accreditation, please complete the participation evaluation and use that certificate as proof of attendance to submit to your accrediting body.

Maintenance of Certification (MOC)
Successful completion of each CME activity in this course, which includes participation in the evaluation component, enables the participant to earn up to 55 points in the American Board of Internal Medicine (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

For questions about content or obtaining CME credit, please contact the Endocrine Society at info@endocrine.org

Faculty and Disclosures

Frances J. Hayes, MB BCh BAO - Program Chair
Associate Chief for Clinic and Education of the Reproductive Endocrine
Massachusetts General Hospital
Associate Professor of Medicine
Harvard Medical School

John D. Carmichael, MD
Clinical Chief
Division of Endocrinology, Diabetes, and Metabolism
Co-Director, USC Pituitary Center
Associate Professor of Clinical Medicine
Keck School of Medicine of the University of Southern California

Natalie Cusano, MD, MS
Associate Professor of Medicine
Zucker School of Medicine at Hofstra/Northwell
Director of the Bone Metabolism Program
Division of Endocrinology at Lenox Hill Hospital

Kanishka Desai, MD
Clinical Associate Professor, Medicine - Endocrinology, Gerontology, & Metabolism
Stanford University

Tobias Else, MD
Associate Professor of Internal Medicine
Division of Metabolism, Endocrinology, and Diabetes
University of Michigan

Jacqueline Jonklaas, MD, PhD, MPH
Professor
Division of Endocrinology
Georgetown University Medical Center

Sangeeta R. Kashyap, MD
Assistant Chief of Clinical Affairs
Division of Endocrinology, Diabetes and Metabolism
Weill Cornell Medicine New York Presbyterian

Margaret Flynn Lippincott, MD
Assistant Professor of Medicine
Harvard Medical School
Physician Investigator
Reproductive Endocrine Unit
Massachusetts General Hospital

Marie E. McDonnell, MD
Chief, Diabetes Section
Division of Endocrinology Diabetes and Hypertension
Brigham and Women's Hospital
Associate Professor of Medicine
Harvard Medical School

Stephanie T. Page, MD, PhD
Professor/Head, Division of Metabolism, Endocrinology, and Nutrition
Co-Director, UW Medicine Diabetes Institute
Robert B. McMillen Professor of Medicine in Lipid Research
University of Washington School of Medicine

Anne L. Peters, MD
Professor of Clinical Medicine
Keck School of Medicine of the University of Southern California

STATEMENT OF INDEPENDENCE
As a provider of CME accredited by the Accreditation Council for Continuing Medical Education, the Endocrine Society has a policy of ensuring that the content and quality of this educational activity are balanced, independent, objective, and scientifically rigorous. The scientific content of this activity was developed under the supervision of the Endocrine Society’s peer reviewers.

DISCLOSURE POLICY
The faculty, committee members, and staff who are in position to control the content of this activity are required to disclose to the Endocrine Society and to learners any relevant financial relationship(s) of the individual that have occurred within the last 12 months with any commercial interest(s) whose products or services are related to the content. Financial relationships are defined by remuneration in any amount from the commercial interest(s) in the form of grants; research support; consulting fees; salary; ownership interest (e.g., stocks, stock options, or ownership interest excluding diversified mutual funds); honoraria or other payments for participation in speakers' bureaus, advisory boards, or boards of directors; or other financial benefits. The intent of this disclosure is not to prevent planners with relevant financial relationships from planning or delivery of content, but rather to provide learners with information that allows them to make their own judgments of whether these financial relationships may have influenced the educational activity with regard to exposition or conclusion.

The Endocrine Society has reviewed all disclosures and resolved or managed all identified conflicts of interest, as applicable.

The following faculty reported relevant financial relationships:

John D. Carmichael, MD, has served as an advisory board member for Camurus, Novo Nordisk, Recordati, and Xeris. He is also a member of the American Association of Clinical Endocrinologists (Pituitary, Adrenal, and Neuroendocrine Disease State Network) and the Pituitary Society.

Natalie E. Cusano, MD, MS, has served as a research investigator for Shire/Takeda, a speaker for Alexion Pharmaceuticals, and a consultant for Ascendis Pharma. She has also spoken for Alexion and serves on the Editorial Board for Endocrine Practice.

Tobias Else, MD, has served as a co-investigator for Corcept Pharmaceuticals and Merck; an advisory board member for Merck and Lantheus; and a committee member for VHL Alliance.

Sangeeta R. Kashyap, MD, has served as a consultant and coinvestigator to GI Dynamics; she has received research support from Fractyl, Inc; and she is chief medical officer of Gila Therapeutics.

Marie E. McDonnell, MD, has served as a trial event adjudicator for a trial conducted by Eisai and receives research funding from Lilly, Inc, that is paid to her institution.

Stephanie Page, MD, PhD, is an editor at UpToDate and has served as a consultant to Pharmajor International.

Anne L. Peters, MD, has served as an advisory board member for Abbott Diabetes Care, Medscape, Novo Nordisk, Vertex, and Zealand and as a consultant for Blue Circle Health. She has received research support from Dexcom, Insulet, and Abbott Diabetes Care. She has stock options in Omada Health and Teladoc.

The following faculty reported no relevant financial relationships: Kaniksha Desai, MD; Frances J. Hayes, MB BCh, BAO; Jacqueline Jonklaas, MD, PhD, MPH; and Margaret Flynn Lippincott, MD

The medical editor for this activity reported no relevant financial relationships: Abbie L. Young, MS, CGC, ELS(D)

Endocrine Society staff associated with the development of content for this activity reported no relevant financial relationships.

ACKNOWLEDGEMENT OF COMMERCIAL SUPPORT
The activity is not supported by educational grant(s) or other funds from any commercial supporters.  

Summary
Availability: On-Demand
Expires on Dec 31, 2025
Cost: Member: $179.00
Non-Member: $229.00
In-Training Member: $149.00
Resident Member: $149.00
Resident Non-Member: $229.00
Credit Offered:
55 AMA PRA Category 1 Credits
55 ABIM-MOC Points
55 Participation Credits
Contains: 2 Courses
Recommended
   
     EndoCareers | Contact Us | Privacy Policy | Terms of Use CONNECT WITH US                
       © 2021 Copyright Endocrine Society. All rights reserved.
2055 L Street NW, Suite 600 | Washington, DC 20036      
 202.971.3636 | 888.363.6274
      
   
Android App Download IOS App Download Powered By